|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5600 CAD | -1.75% |
|
-3.45% | -13.85% |
| 06-17 | Thiogenesis Therapeutics Appoints Gilad Aharon to its Board | MT |
| 06-17 | Thiogenesis Therapeutics, Corp. Appoints Gilad Aharon to Its Board of Directors | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.75% | -3.45% | -1.75% | +14.29% | -13.85% | -28.21% | -24.32% | - | - | 20.54M | |
| +0.70% | +0.90% | +1.37% | +4.52% | -8.01% | -11.34% | -9.89% | -23.21% | +206.70% | 42.75B | |
| +3.31% | +9.22% | +12.90% | +66.13% | +104.63% | +308.19% | +562.02% | +379.95% | - | 34.65B | |
| +2.84% | +3.80% | -7.83% | -4.30% | -11.08% | +6.87% | +34.93% | -16.05% | +768.65% | 30.03B | |
| -1.70% | -7.34% | -2.92% | +0.45% | -25.57% | +8.51% | -22.34% | -30.00% | +164.62% | 28B | |
| -0.57% | +4.45% | -0.50% | -12.99% | +0.71% | +12.31% | +20.42% | -21.80% | +165.07% | 24.83B | |
| -0.14% | +7.06% | -2.87% | - | - | - | - | - | - | 14.34B | |
| +0.68% | -3.13% | +9.40% | +1.19% | -18.06% | +52.04% | +107.47% | +159.21% | - | 13.14B | |
| -0.19% | -2.03% | +2.41% | +1.36% | +0.61% | +5.62% | +4.63% | -32.35% | +95.42% | 12.61B | |
| -0.26% | +0.41% | +2.21% | +3.42% | -6.31% | +100.27% | +80.69% | +96.14% | +230.01% | 12.25B | |
| +1.91% | -2.61% | +28.32% | +50.30% | -19.88% | +1.69% | -37.64% | -31.19% | +128.02% | 11.18B | |
| +1.46% | -1.63% | +23.39% | +17.75% | -7.26% | +27.33% | -11.90% | -47.70% | +125.36% | 8.91B | |
| +4.20% | +2.52% | +16.55% | +4.42% | -13.90% | -26.43% | - | - | - | 9.13B | |
| +5.35% | +7.26% | +30.41% | +14.03% | -1.48% | +15.58% | -26.18% | -46.34% | +110.42% | 9.07B | |
| -4.29% | -3.00% | -15.04% | -22.17% | -31.48% | +1,456.60% | +413.70% | +190.49% | +1,275.00% | 7.88B | |
| +1.01% | -1.26% | +9.38% | -8.65% | -21.94% | -24.59% | -29.21% | -29.75% | +54.67% | 7.64B | |
| +4.56% | +13.84% | -11.92% | -2.24% | -4.22% | +556.99% | +1,658.94% | -12.54% | - | 7.87B | |
| +1.08% | +0.16% | +20.97% | +65.40% | +60.79% | +53.39% | +39.76% | +84.23% | +8.75% | 7.5B | |
| +0.59% | +9.00% | +13.51% | +14.27% | +16.22% | +94.72% | +249.69% | +90.98% | - | 7.44B | |
| -18.96% | -39.00% | -56.78% | -54.47% | -42.81% | -81.04% | +1,807.86% | - | - | 5.95B | |
| Average | -0.30% | -0.46% | +3.56% | +8.04% | -2.26% | +133.08% | +267.70% | +44.38% | +277.72% | 14.76B | |
| Weighted average by Cap. | +0.50% | +0.88% | +3.55% | +10.76% | +4.95% | +104.65% | +186.53% | +54.42% | +289.83% |
- Stock Market
- Stocks
- TTI Stock
- Sector Thiogenesis Therapeutics, Corp.
Select your edition
All financial news and data tailored to specific country editions
